LLY

805.71

-1.45%↓

UNH

556.95

-1.68%↓

JNJ

158.12

-1.16%↓

NVO

109.92

-1.81%↓

ABBV

200.71

-1.24%↓

LLY

805.71

-1.45%↓

UNH

556.95

-1.68%↓

JNJ

158.12

-1.16%↓

NVO

109.92

-1.81%↓

ABBV

200.71

-1.24%↓

LLY

805.71

-1.45%↓

UNH

556.95

-1.68%↓

JNJ

158.12

-1.16%↓

NVO

109.92

-1.81%↓

ABBV

200.71

-1.24%↓

LLY

805.71

-1.45%↓

UNH

556.95

-1.68%↓

JNJ

158.12

-1.16%↓

NVO

109.92

-1.81%↓

ABBV

200.71

-1.24%↓

LLY

805.71

-1.45%↓

UNH

556.95

-1.68%↓

JNJ

158.12

-1.16%↓

NVO

109.92

-1.81%↓

ABBV

200.71

-1.24%↓

Home・Stock List・Teleflex Inc

Teleflex Inc

Open

Sector Healthcare

207.12 -1.45

Buy Sell

Overview

Share price change

24h

Current

Min

206.2

Max

211.09

Key metrics
By Trading Economics
Income	31M 111M
Sales	15M 764M
P/E Sector Avg	44.24 104.138
EPS	3.49
Dividend yield	0.55
Profit margin	14.521
Employees	14,500
EBITDA	26M 213M

Recommendations
By TipRanks
Recommendations	Buy
12 Months Forecast	+17.75 upside

Dividends
By Dow Jones
Dividend yield Sector Avg	0.55% 1.72%
Next Dividend date	13 Dec 2024

Market Stats
By TradingEconomics
Market Cap	292M 9.8B
Previous open	208.57
Previous close	207.12

News Sentiment

By Acuity

43%

57%

152 / 390 Healthcare

Technical Score

By Trading Central

Confidence

Very Strong Bearish Evidence

195.5101 / 235.44 Support & Resistance

Teleflex Inc Chart

Past performance is not a reliable indicator of future results.

Related News

3 Nov 2024, 23:05 UTC

Top News

Fitch Affirms Australia's Sovereign AAA Rating, But Warns Of Mounting Budget Risks

3 Nov 2024, 21:12 UTC

Earnings

Westpac Says Annual Profit Falls 3%, Upbeat on Prospects -- Update

3 Nov 2024, 20:59 UTC

Earnings

Westpac Says Annual Profit Falls 3%, Upbeat on Prospects

3 Nov 2024, 23:34 UTC

Top News

Stocks Poised for Lower Open -- Barrons.com

3 Nov 2024, 23:16 UTC

Top News

Earnings

Berkshire Hathway Earnings Weren't as Bad as They Looked -- Barrons.com

3 Nov 2024, 22:50 UTC

Acquisitions, Mergers, Takeovers

Santos Says Working Interest in PNG LNG Now 39.9%

3 Nov 2024, 22:50 UTC

Acquisitions, Mergers, Takeovers

Santos Says Kumul to Assume $90 Million of Project Finance Debt Associated With Stake

3 Nov 2024, 22:49 UTC

Acquisitions, Mergers, Takeovers

Santos Says Final Payment Takes Total Cash Consideration to $602 Million

3 Nov 2024, 22:49 UTC

Acquisitions, Mergers, Takeovers

Santos Receives Final $241 Million Payment From Kumul

3 Nov 2024, 22:48 UTC

Acquisitions, Mergers, Takeovers

Santos Completes Sale of 2.6% Interest in PNG LNG to Kumul Petroleum

3 Nov 2024, 20:37 UTC

Earnings

Westpac FY 2024 Deposits Increased 5% to A$674 Billion

3 Nov 2024, 20:37 UTC

Earnings

Westpac FY 2024 Loans Increased 4% to A$807 Billion

3 Nov 2024, 20:37 UTC

Earnings

Westpac FY 2024 Impairment Charges 7 Bps of Loans

3 Nov 2024, 20:37 UTC

Earnings

Westpac FY 2024 Operating Expenses A$10.94 Billion, Up 7% Excluding Notable Items

3 Nov 2024, 20:36 UTC

Earnings

Westpac FY 2024 Non-Interest Income A$2.84 Billion, Down 15%

3 Nov 2024, 20:35 UTC

Earnings

Westpac FY 2024 CET1 Level 2 Capital Ratio 12.5%, Up 11 Bps

3 Nov 2024, 20:35 UTC

Earnings

Westpac Raises Share Buyback Program by A$1 Billion

3 Nov 2024, 20:35 UTC

Earnings

Westpac Final Dividend A$0.76/Share

3 Nov 2024, 20:33 UTC

Earnings

Westpac FY 2024 Net Interest Margin Down 1 Bps at 1.95%

3 Nov 2024, 20:32 UTC

Earnings

Westpac FY 2024 Revenue A$21.59 Billion, Flat on FY 2023

3 Nov 2024, 20:32 UTC

Earnings

Westpac FY Net Profit A$6.99 Billion, Down 3%

3 Nov 2024, 18:09 UTC

Top News

Boeing Had a Big Week. This One Is Even Bigger. -- Barrons.com

3 Nov 2024, 10:30 UTC

Top News

Fed Prepares Rate Cut Amid Economic Contradictions -- WSJ

3 Nov 2024, 03:00 UTC

Top News

Disgraced Lebanese Central Banker Who Was a Fugitive Now Awaits His Fate -- WSJ

2 Nov 2024, 13:53 UTC

Top News

Earnings

Acquisitions, Mergers, Takeovers

Warren Buffett's Berkshire Hathaway Slashes Apple Stake Again -- Update

2 Nov 2024, 13:44 UTC

Earnings

Acquisitions, Mergers, Takeovers

Berkshire Sold 25% of Its Apple Stock in the Third Quarter -- Barrons.com

2 Nov 2024, 13:00 UTC

Top News

China's EV Makers Set Sights on Latin America in Global Expansion -- WSJ

2 Nov 2024, 12:58 UTC

Earnings

Acquisitions, Mergers, Takeovers

Berkshire Sold 25% of Its Apple Stock in the Third Quarter -- Barrons.com

2 Nov 2024, 12:48 UTC

Top News

Earnings

Acquisitions, Mergers, Takeovers

Warren Buffett's Berkshire Hathaway Slashes Apple Stake Again -- WSJ

2 Nov 2024, 12:32 UTC

Earnings

Berkshire Profits Fell 6% in Third Quarter. The Buybacks Are on Pause. -- Barrons.com

Peer Comparison

Price change

Teleflex Inc Forecast

Price Target

By TipRanks

17.75% upside

12 Months Forecast

Average 248.71 USD 17.75%

High 285 USD

Low 214 USD

Based on 9 Wall Street analysts offering 12 month price targets forTeleflex Inc - Dist in the last 3 months.

Rating Consensus

By TipRanks

Buy

9 ratings

Buy

Hold

Sell

Based on 9 analysts giving stock ratings to Teleflex Inc - Dist in the past 3 months.

Technical Score

By Trading Central

195.5101 / 235.44Support & Resistance

Recent bearish events outweigh bullish events.

Bearish events outweigh bullish events.

There is one bearish event.

Sentiment

By Acuity

152 / 390 Healthcare

Financials

Selling and administration expenses

Operating expenses

Pre-tax profit

Sales

Cost of sales

Gross profit on sales

Interest expense on debt

EBITDA

Operating profit

About Teleflex Inc

Teleflex Incorporated is a provider of medical technology products. The Company primarily designs, develops, manufactures and supplies single-use medical devices used by hospitals and healthcare providers for common diagnostic and therapeutic procedures in critical care and surgical applications. The Company operates through four segments: Americas; Europe, Middle East and Africa (EMEA); Asia (Asia Pacific), and Original Equipment Manufacturer and Development Services (OEM). Its product categories include vascular access, anesthesia, interventional, surgical, interventional urology, and urology. The Company's specialty product line of urology products provides bladder management. The product portfolio consists of a range of catheters, including Foley, intermittent, external and suprapubic; urine collectors; catheterization accessories, and products for operative endourology marketed under the Rusch brand name.